Glofish has a total of 98 patents globally, out of which 33 have been granted. Of these 98 patents, more than 83% patents are active. United States of America is where Glofish has filed the maximum number of patents, followed by United Kingdom and Mexico. Parallelly, United States of America
Invetx has a total of 57 patents globally, out of which 5 have been granted. Of these 57 patents, more than 92% patents are active. United States of America is where Invetx has filed the maximum number of patents, followed by Hong Kong (S.A.R.) and Australia. Parallelly, United States of
Innovasea Systems has a total of 122 patents globally, out of which 71 have been granted. Of these 122 patents, more than 86% patents are active. United States of America is where Innovasea Systems has filed the maximum number of patents, followed by Canada and Europe. Parallelly, United States of
Ibex Biosciences has a total of 36 patents globally, out of which 1 has been granted. Of these 36 patents, more than 88% patents are active. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Ibex Biosciences. Ibex Biosciences
Pure Fishing has a total of 213 patents globally, out of which 118 have been granted. Of these 213 patents, more than 66% patents are active. United States of America is where Pure Fishing has filed the maximum number of patents, followed by Europe and China. Parallelly, United States of
Nanoguard Technologies has a total of 59 patents globally, out of which 20 have been granted. Of these 59 patents, more than 91% patents are active. United States of America is where Nanoguard Technologies has filed the maximum number of patents, followed by China and Europe. Parallelly, United States of
Microvascular Tissues has a total of 58 patents globally, out of which 33 have been granted. Of these 58 patents, more than 63% patents are active. United States of America is where Microvascular Tissues has filed the maximum number of patents, followed by Europe and Austria. Parallelly, United States of
Augmenta Bioworks has a total of 23 patents globally, out of which 3 have been granted. Of these 23 patents, more than 56% patents are active. United States of America is where Augmenta Bioworks has filed the maximum number of patents, followed by Japan and Europe. Parallelly, United States of
Khloris Biosciences has a total of 13 patents globally, out of which no patents have been granted. Of these 13 patents, more than 76% patents are active. United States of America is where Khloris Biosciences has filed the maximum number of patents, followed by Japan and Europe. Parallelly, United States
Kelonia Therapeutics has a total of 9 patents globally, out of which no patents have been granted. Of these 9 patents, more than 88% patents are active. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Kelonia Therapeutics. Kelonia
Interested in in-depth patent data and patent portfolio analysis of Tesla. Get your report now.